INSTANYL

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

fentanyl citrate, Quantity: 0.785 mg/mL (Equivalent: fentanyl, Qty 0.5 mg/mL)

제공처:

Takeda Pharmaceuticals Australia Pty Ltd

INN (International Name):

Fentanyl citrate

약제 형태:

Spray, nasal

구성:

Excipient Ingredients: monobasic sodium phosphate dihydrate; dibasic sodium phosphate dihydrate; purified water

관리 경로:

Nasal

패키지 단위:

2 bottles per carton, 8 bottles per carton, 6 bottles per carton, 10 bottles per carton

처방전 유형:

(S8) Controlled Drug

치료 징후:

Instanyl is indicated for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain.

제품 요약:

Visual Identification: Nasal spray; Container Type: Bottle, with integral pump - manual actuated; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2013-06-17